Quick Answer
Decoy Therapeutics Inc. reported Total Assets of $11.06 million for the year ending 2025.
- Decoy Therapeutics Inc. showed an increase of +265.8% in Total Assets from 2024 to 2025.
- This data is from Decoy Therapeutics Inc.'s annual report (Form 10-K), filed with the SEC on March 31, 2026.
- XBRL data for this metric is available from 2014 to 2025 (12 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2015: $111.94 million | Q2 2015: $107.20 million | Q3 2015: $100.76 million | Q1 2016: $87.25 million | Q2 2016: $78.23 million | Q3 2016: $69.95 million | Q1 2017: $55.50 million | Q2 2017: $49.63 million | Q3 2017: $41.21 million | Q1 2018: $26.03 million | Q2 2018: $17.21 million | Q3 2018: $13.94 million | Q1 2019: $8.18 million | Q2 2019: $7.14 million | Q3 2019: $14.46 million | Q2 2020: $18.56 million | Q3 2020: $23.06 million | Q1 2021: $50.77 million | Q2 2021: $47.40 million | Q3 2021: $44.26 million | Q1 2022: $35.51 million | Q2 2022: $33.65 million | Q3 2022: $19.72 million | Q1 2023: $10.06 million | Q2 2023: $12.06 million | Q3 2023: $8.40 million | Q1 2024: $4.88 million | Q2 2024: $3.55 million | Q3 2024: $3.86 million | Q1 2025: $2.34 million | Q2 2025: $1.39 million | Q3 2025: $6.10 million.
- Over the full 12 years of available data (2014 to 2025), Decoy Therapeutics Inc.'s Total Assets has declined by 69.0%.
- Historical annual values: Fiscal year 2025: $11.06 million | Fiscal year 2024: $3.02 million | Fiscal year 2023: $6.59 million | Fiscal year 2022: $14.65 million | Fiscal year 2021: $40.83 million | Fiscal year 2020: $24.93 million | Fiscal year 2019: $13.89 million | Fiscal year 2018: $6.61 million | Fiscal year 2017: $34.99 million | Fiscal year 2016: $63.21 million | Fiscal year 2015: $95.07 million | Fiscal year 2014: $35.61 million.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: